|Positive WB detected in||mouse brain tissue, mouse heart tissue|
|Positive IP detected in||mouse brain tissue|
|Positive FC detected in||HeLa cells|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:1000 for WB|
|Sample-dependent, check data in validation data gallery|
The immunogen of 26187-1-AP is DRP1 (N-terminal) Fusion Protein expressed in E. coli.
|Tested Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||DRP1 (N-terminal) fusion protein Ag24249|
|Full Name||dynamin 1-like|
|Calculated molecular weight||710 aa, 79 kDa|
|Observed molecular weight||70-78 kDa|
|GenBank accession number||BC024590|
|Gene ID (NCBI)||10059|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
DNM1L(Dynamin-1-like protein) , also known as dynamin-related protein 1 (DRP1), belongs to the dynamin family of large GTPases that mediate membrane remodeling during a variety of cellular processes. DNM1L has an important role in the division of growing mitochondria and peroxisomes and also mediates outer mitochondrial membrane fission in mammalian cells. DNM1L is ubiquitously expressed with abundant expression in skeletal muscle, heart, kidney and brain.Variable isoforms of DNM1L have been reported in a tissue-specific manner due to the alternative splicing.
|Product Specific Protocols|
|WB protocol for DRP1 (N-terminal) antibody 26187-1-AP||Download protocol|
|IP protocol for DRP1 (N-terminal) antibody 26187-1-AP||Download protocol|
|FC protocol for DRP1 (N-terminal) antibody 26187-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Asian J Androl
Mannose inhibits the growth of prostate cancer through a mitochondrial mechanism.
Biochem Biophys Res Commun
DUSP1 overexpression attenuates renal tubular mitochondrial dysfunction by restoring Parkin-mediated mitophagy in diabetic nephropathy.
EMBO Mol Med
High-throughput screening identifies suppressors of mitochondrial fragmentation in OPA1 fibroblasts.